Fusion protein comprising anti-mesothelin antibody, anti-CD3 antibody or anti-EGFR antibody, bispecific or trispecific antibody comprising same, and uses thereof
US-12534518-B2 · Jan 27, 2026 · US
This page is not indexed by search engines while we improve data quality.
Lim Yangmi patents
Lim Yangmi is listed as an inventor on 4 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Lim Yangmi |
| Total patents | 4 |
| First publication | Apr 25, 2019 |
| Latest publication | Jan 27, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
Fusion protein comprising anti-mesothelin antibody, anti-cd3 antibody or anti-egfr antibody, bispecific or trispecific antibody comprising same, and uses thereof
US-2022251176-A1 · Aug 11, 2022 · US
Pharmaceutical composition for inhibiting metastasis of cancer, comprising, as active ingredient, antibody that specifically binds to epidermal growth factor receptor
US-11198733-B2 · Dec 14, 2021 · US
Pharmaceutical composition for inhibiting metastasis of cancer, comprising, as active ingredient, antibody that specifically binds to epidermal growth factor receptor
US-2019119388-A1 · Apr 25, 2019 · US
Recent patents
Latest publications not already listed above.
No data yet.
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Green Cross Corp | 4 |
| Mogam Inst Biomedical Res | 4 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C07K2317/565 | 4 |
| C07K2317/73 | 4 |
| C07K16/2863 | 4 |
| A61K2039/505 | 4 |
| A61P35/04 | 2 |